+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

X-ray crystallography: Assessment and validation of protein-small molecule complexes for drug discovery



X-ray crystallography: Assessment and validation of protein-small molecule complexes for drug discovery



Expert Opinion on Drug Discovery 6(8): 771-782



INTRODUCTION: Crystallography is the key initial component for structure-based and fragment-based drug design and can often generate leads that can be developed into high potency drugs. Therefore, huge sums of money are committed based on the outcome of crystallography experiments and their interpretation. AREAS COVERED: This review discusses how to evaluate the correctness of an X-ray structure, focusing on the validation of small molecule-protein complexes. Various types of inaccuracies found within the PDB are identified and the ramifications of these errors are discussed. The reader will gain an understanding of the key parameters that need to be inspected before a structure can be used in drug discovery efforts, as well as an appreciation of the difficulties of correctly interpreting electron density for small molecules. The reader will also be introduced to methods for validating small molecules within the context of a macromolecular structure. EXPERT OPINION: One of the reasons that ligand identification and positioning, within a macromolecular crystal structure, is so difficult is that the quality of small molecules widely varies in the PDB. For this reason, the PDB can not always be considered a reliable repository of structural information pertaining to small molecules, and this makes the derivation of general principles that govern small molecule-protein interactions more difficult.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 056966411

Download citation: RISBibTeXText

PMID: 21779303

DOI: 10.1517/17460441.2011.585154


Related references

Biophysical Analysis of the Protein-Small Molecule Interactions to Develop Small Molecule Drug Discovery. Yakugaku Zasshi 138(8): 1033-1041, 2018

Discovery of selective, small-molecule inhibitors of RNA complexes--I. The Tat protein/TAR RNA complexes required for HIV-1 transcription. Bioorganic and Medicinal Chemistry 5(6): 1173-1184, 1997

Protein-protein interactions as targets for small molecule drug discovery. Biopolymers 84(6): 535-552, 2006

Small-molecule stabilization of protein-protein interactions: an underestimated concept in drug discovery?. Angewandte Chemie 51(9): 2012-2018, 2012

Discovery of selective, small-molecule inhibitors of RNA complexes1. The tat protein/TAR RNA complexes required for HIV-1 transcription. Bioorganic & Medicinal Chemistry 5(6): 1173-1184, 1997

Applications of protein arrays for small molecule drug discovery and characterization. Biotechnology and Genetic Engineering Reviews 22: 197-211, 2008

Applications of Protein Arrays for Small Molecule Drug Discovery and Characterization. Biotechnology and Genetic Engineering Reviews 22 2006: 7-211, 2006

Safety assessment considerations and strategies for targeted small molecule cancer therapeutics in drug discovery. Toxicologic Pathology 38(1): 165-168, 2010

Discovery and validation of small-molecule heat-shock protein 90 inhibitors through multimodality molecular imaging in living subjects. Proceedings of the National Academy of Sciences of the United States of America 109(37): E2476-E2485, 2012

Targeting the unactivated conformations of protein kinases for small molecule drug discovery. Expert Opinion on Drug Discovery 3(6): 595-605, 2008

A fully integrated protein crystallization platform for small-molecule drug discovery. Journal of Structural Biology 142(1): 207-217, 2003

Structure-Based Macrocycle Design in Small-Molecule Drug Discovery and Simple Metrics To Identify Opportunities for Macrocyclization of Small-Molecule Ligands. Journal of Medicinal Chemistry 2019, 2019

Drug discovery conference 2008. Small-Molecule Drug Discovery: From Early Stage to the Clinic. Idrugs 11(3): 164-168, 2008

Efficient combinatorial chemistry/high throughput screening paradigm for small molecule Drug Discovery Maximizing the discovery of drug candidates and minimizing waste. Abstracts of Papers American Chemical Society 224(1-2): BTEC 8, 2002

Small molecule crystallography in drug design. Current Pharmaceutical Design 7(7): 529-545, 2001